ICCC ImmuCell Corporation
$9.85▼ -0.66%
Healthcare
Other
After hours
$9.85▲ +0.00%
Sep 11, 7:30 PM ET
Volume 8.1K
Avg Volume (10D) 11.4K
Key Metrics & Fundamentals
Market Cap
$89.46M
P/E Ratio
140.7
Div Yield
–%
52W Range
4.52 - 12.10
% vs 50 MA
-6.69%
% vs 200 MA
21.35%
RSI-14
40.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.35
Free Cash Flow
$2.29M
Gross Rev
$7.19M
Gross Profit
$2.44M
EBITDA
$2.44M
COGS
$4.75M
Operating Exp
$502,288
Operating Income
$1.93M
EBIT
$1.93M
Pretax Income
$1.88M
Net Income
$1.83M
EPS (Diluted)
0.20
Price & Volume History
Loading chart…
Recent News
ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2
Zacks · Aug 27, 2026 2:10 PM
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 10:45 PM
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
GuruFocus.com · Aug 14, 2026 11:01 PM
ImmuCell Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 2:04 PM
ImmuCell Corporation Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire · Aug 13, 2026 8:05 PM
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire · Aug 6, 2026 8:05 PM
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
Zacks · Jul 10, 2026 1:45 PM
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
GlobeNewswire · Jul 9, 2026 8:05 PM
The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell
Zacks · Jun 26, 2026 9:26 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ICCC's money flow as a full page
Social Sentiment
No Reddit posts found for ICCC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.